Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes

Study overview

The overall goal of the study is to create a standardized, stakeholder-informed system within EMRs, that will enable an equitable and regular prescription and documentation of advanced diabetes technologies. This will reduce racial disparities and generate an understanding of the reasons behind prescription decisions. The study will highlight the development and implementation an EMR-based Best Practice Advisory (BPA). The study will answer whether the EMR-based BPA can effectively reduce disparities. Additionally, it will explore why providers may not prescribe advanced diabetes technologies. Patients will also be surveyed to understand their perspectives on developing the EMR-based BPA.

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Collaborators and Investigators

T1D Exchange, United States,

Osagie Ebekozien, PRINCIPAL_INVESTIGATOR, T1DExchange

Nestoras Mathioudakis, STUDY_DIRECTOR, Johns Hopkins University

Risa Wolf, STUDY_DIRECTOR, Johns Hopkins Pediatrics

Study Record Dates

2027-07-30